This is a partitioner-only product. Purchasing this product/supplement requires either:
Researched Nutritionals
Boluoke Lumbrokinase - Researched Nutritionals
Boluoke Lumbrokinase - Researched Nutritionals
Couldn't load pickup availability
Boluoke Lumbrokinase - Researched Nutritionals in New Zealand
Healthy Coagulation & Biofilm Defense
Boluoke® (lumbrokinase) is the only fully researched oral enzyme on the market supporting a healthier blood state, and it shows great promise in supporting a healthy coagulation/fibrinolysis balance in the body. Coagulation system is a complicated and highly regulated system. Modern lifestyles often tip the balance towards hypercoagulation (thick blood) and rarely towards hypocoagulation. For most people, Boluoke® can support the body in keeping the system in a more balanced state.
Lumbrokinase is a more potent enzyme preparation than nattokinase. One of the advantages of Boluoke® (lumbrokinase) is that it does not interfere with the clotting cascade, but instead, works by reducing fibrinogen and fibrin. Boluoke® does not affect INR or aPTT, thus is compatible with Coumadin® or heparin.
Features
- 20 mg of the active ingredient
- Promotes healthy coagulation
- Supports body’s antibiofilm process
- Clinically studied in double blind controlled studies
- Lumbrokinase has been safely used together with Heparin® or Coumadin® in various clinical studies
Suggested Use
As a dietary supplement, if Boluoke® is to be taken for chronic conditions, it should be taken at the dose of 1 capsule 1 to 3 times daily 30 minutes before the meal. However, the practitioner may recommend 2 capsules 3 times daily for 3 to 6 weeks in conditions with severe hypoperfusion.
Cautions
Lumbrokinase strongly inhibits adhesion molecules on platelets. Thus it is advised that lumbrokinase not be taken concurrently with other strong antiplatelet medications like Plavix® or Ticlid®. General contra-indications for Boluoke® are: allergy to lumbrokinase or earthworm; recent surgery, lumbar puncture, or arterial puncture; trauma; aneurysm; active internal bleeding or GI ulceration; or any other bleeding disorders. The patient should stop Boluoke® 1 week prior to surgery, and should be able to resume taking Boluoke® 15 days after surgery or at the physician’s discretion.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Share
